257
Participants
Start Date
October 31, 2012
Primary Completion Date
February 29, 2016
Study Completion Date
February 29, 2016
Tolvaptan
IV furosemide plusTolvaptan (given at 0, 24 and 48 hours)
Placebo
IV furosemide plus oral placebo (given at 0, 24 and 48 hours)
Montefiore Medical Center, The Bronx
Allegheny Valley Hospital, Natrona Heights
Grand View - Lehigh Valley Health Services, Sellersville
Inova Heart and Vascular Institute, Falls Church
University of North Carolina at Chapel Hill, Chapel Hill
Duke University Medical Center, Durham
Novant Health Heart and Vascular, Charlotte
Southeastern Regional Medical Center, Lumberton
Emory University School of Medicine, Atlanta
Northeast Georgia Heart Center, Gainesville
Mercer University School of Medicine, Macon
The Christ Hospital, Cincinnati
University of Cincinnati Medical Center, Cincinnati
Indiana University School of Medicine, Indianapolis
Hennepin County Medical Center, Minneapolis
University of Chicago, Chicago
UT Southwestern Medical center, Dallas
University of Colorado at Denver and Health Sciences Center, Aurora
Lead Sponsor
Duke University
OTHER